471 related articles for article (PubMed ID: 21531516)
1. Normal tissue complication probability estimation by the Lyman-Kutcher-Burman method does not accurately predict spinal cord tolerance to stereotactic radiosurgery.
Daly ME; Luxton G; Choi CY; Gibbs IC; Chang SD; Adler JR; Soltys SG
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2025-32. PubMed ID: 21531516
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic radiosurgery for treatment of spinal metastases recurring in close proximity to previously irradiated spinal cord.
Choi CY; Adler JR; Gibbs IC; Chang SD; Jackson PS; Minn AY; Lieberson RE; Soltys SG
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):499-506. PubMed ID: 20133079
[TBL] [Abstract][Full Text] [Related]
3. Lyman-Kutcher-Burman NTCP model parameters for radiation pneumonitis and xerostomia based on combined analysis of published clinical data.
Semenenko VA; Li XA
Phys Med Biol; 2008 Feb; 53(3):737-55. PubMed ID: 18199912
[TBL] [Abstract][Full Text] [Related]
4. Reirradiation human spinal cord tolerance for stereotactic body radiotherapy.
Sahgal A; Ma L; Weinberg V; Gibbs IC; Chao S; Chang UK; Werner-Wasik M; Angelov L; Chang EL; Sohn MJ; Soltys SG; Létourneau D; Ryu S; Gerszten PC; Fowler J; Wong CS; Larson DA
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):107-16. PubMed ID: 20951503
[TBL] [Abstract][Full Text] [Related]
5. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
Luxton G; Hancock SL; Boyer AL
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):267-84. PubMed ID: 15093924
[TBL] [Abstract][Full Text] [Related]
6. The benefits of including clinical factors in rectal normal tissue complication probability modeling after radiotherapy for prostate cancer.
Defraene G; Van den Bergh L; Al-Mamgani A; Haustermans K; Heemsbergen W; Van den Heuvel F; Lebesque JV
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1233-42. PubMed ID: 21664059
[TBL] [Abstract][Full Text] [Related]
7. Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer.
Chapet O; Kong FM; Lee JS; Hayman JA; Ten Haken RK
Radiother Oncol; 2005 Nov; 77(2):176-81. PubMed ID: 16256230
[TBL] [Abstract][Full Text] [Related]
8. Delayed radiation-induced myelopathy after spinal radiosurgery.
Gibbs IC; Patil C; Gerszten PC; Adler JR; Burton SA
Neurosurgery; 2009 Feb; 64(2 Suppl):A67-72. PubMed ID: 19165076
[TBL] [Abstract][Full Text] [Related]
9. Probabilities of radiation myelopathy specific to stereotactic body radiation therapy to guide safe practice.
Sahgal A; Weinberg V; Ma L; Chang E; Chao S; Muacevic A; Gorgulho A; Soltys S; Gerszten PC; Ryu S; Angelov L; Gibbs I; Wong CS; Larson DA
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):341-7. PubMed ID: 22713832
[TBL] [Abstract][Full Text] [Related]
10. Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101).
Rancati T; Fiorino C; Gagliardi G; Cattaneo GM; Sanguineti G; Borca VC; Cozzarini C; Fellin G; Foppiano F; Girelli G; Menegotti L; Piazzolla A; Vavassori V; Valdagni R
Radiother Oncol; 2004 Oct; 73(1):21-32. PubMed ID: 15465142
[TBL] [Abstract][Full Text] [Related]
11. Normal tissue complication probability modeling of acute hematologic toxicity in patients treated with intensity-modulated radiation therapy for squamous cell carcinoma of the anal canal.
Bazan JG; Luxton G; Mok EC; Koong AC; Chang DT
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):700-6. PubMed ID: 22414279
[TBL] [Abstract][Full Text] [Related]
12. Tolerance of the spinal cord to stereotactic radiosurgery: insights from hemangioblastomas.
Daly ME; Choi CY; Gibbs IC; Adler JR; Chang SD; Lieberson RE; Soltys SG
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):213-20. PubMed ID: 21481724
[TBL] [Abstract][Full Text] [Related]
13. A new formula for normal tissue complication probability (NTCP) as a function of equivalent uniform dose (EUD).
Luxton G; Keall PJ; King CR
Phys Med Biol; 2008 Jan; 53(1):23-36. PubMed ID: 18182685
[TBL] [Abstract][Full Text] [Related]
14. Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma.
Xu ZY; Liang SX; Zhu J; Zhu XD; Zhao JD; Lu HJ; Yang YL; Chen L; Wang AY; Fu XL; Jiang GL
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):189-95. PubMed ID: 16542787
[TBL] [Abstract][Full Text] [Related]
15. Proposal of human spinal cord reirradiation dose based on collection of data from 40 patients.
Nieder C; Grosu AL; Andratschke NH; Molls M
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):851-5. PubMed ID: 15708265
[TBL] [Abstract][Full Text] [Related]
16. Spine radiosurgery: a dosimetric analysis in 124 patients who received 18 Gy.
Schipani S; Wen W; Jin JY; Kim JK; Ryu S
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):e571-6. PubMed ID: 22975607
[TBL] [Abstract][Full Text] [Related]
17. Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.
Liang X; Penagaricano J; Zheng D; Morrill S; Zhang X; Corry P; Griffin RJ; Han EY; Hardee M; Ratanatharathom V
Radiat Oncol; 2016 Jan; 11():10. PubMed ID: 26800883
[TBL] [Abstract][Full Text] [Related]
18. Spinal cord tolerance for stereotactic body radiotherapy.
Sahgal A; Ma L; Gibbs I; Gerszten PC; Ryu S; Soltys S; Weinberg V; Wong S; Chang E; Fowler J; Larson DA
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):548-53. PubMed ID: 19765914
[TBL] [Abstract][Full Text] [Related]
19. Extrapolation of normal tissue complication probability for different fractionations in liver irradiation.
Tai A; Erickson B; Li XA
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):283-9. PubMed ID: 19289259
[TBL] [Abstract][Full Text] [Related]
20. Mathematical model for evaluating incidence of acute rectal toxicity during conventional or hypofractionated radiotherapy courses for prostate cancer.
Strigari L; Arcangeli G; Arcangeli S; Benassi M
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1454-60. PubMed ID: 18990503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
